MedTrace Logo

CoMplete™ Acetabular Hip System

NCT01543230 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2014-04-08

No results posted yet for this study

Summary

The primary objective of this investigation is to evaluate survivorship at ten years. For this post approval study (PAS), a maximum acceptable hazard of revision is assumed to be a constant 1% per year.

Conditions

  • Non-inflammatory Degenerative Joint Disease
  • Osteoarthritis
  • Post-traumatic Arthritis

Interventions

DEVICE

Total hip replacement

Total hip arthroplasty (THA) using CoMplete™ Acetabular Hip System

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Dave Whalen, BS, DC · DePuy Orthopaedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01543230 on ClinicalTrials.gov